Drug Profile
Recombinant epidermal growth factor biosimilar - Elea
Alternative Names: r-hu-EGF - EleaLatest Information Update: 24 Nov 2021
Price :
$50
*
At a glance
- Originator Elea
- Class Antiulcers; Cytoprotectives; Growth factors
- Mechanism of Action Epidermal growth factor receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Burns; Diabetic foot ulcer; Wounds